Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | NCF2 |
| Upstream (Parents) |
|---|
| (<<) CD86 → NCF2 |
| (<<) PILRA → NCF2 |
| (<<) SLC7A7 → NCF2 |
| Downstream (Children) |
|---|
| NCF2 → SYCP2 (>>) |
| NCF2 → C15orf48 (>>) |
| NCF2 → SERPINA1 (>>) |
| NCF2 → CCL13 (>>) |
| NCF2 → AQP9 (>>) |
| NCF2 → FCGR2B (>>) |
| NCF2 → CCL3L3///CCL3L1///CCL3 (>>) |
| NCF2 → GK (>>) |
| NCF2 → VSIG4 (>>) |
| NCF2 → IFT81 (>>) |
| NCF2 → CHST11 (>>) |
| NCF2 → APOC4///APOC2 (>>) |
| NCF2 → NRXN1 (>>) |
| NCF2 → C5AR1 (>>) |
| NCF2 → TLR2 (>>) |
| NCF2 → VMO1 (>>) |
| NCF2 → C19orf59 (>>) |
